Cerenis Therapeutics' Series C - II Round

Cerenis Therapeutics raised a round of funding on October 26, 2010. Investors include IRDI-IXO.

Cerenis Therapeutics is a biotechnology company dedicated to the discovery, development and commercialization of novel HDL therapies for the treatment of cardiovascular and metabolic diseases. Cereni…

Articles about Cerenis Therapeutics' Series C - II Round: